Amwell to Participate in Upcoming Investor Conferences Boston, Aug. 22, 2024 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in hybrid care enablement, announced that the company will participate in several investor conferences in September. Ido Schoenberg, M.D., Amwell’s chairman and CEO, and Robert Shepardson, Amwell’s CFO, will participate in the following conferences via fireside chat and one-on-one meetings held throughout the day: September 4, Morgan Stanley 22nd Annual Global Healthcare Conference in New York City; fireside chat at 1:50 p.m. ET. September 5, Wells Fargo Healthca...
Amwell Announces Results for Second Quarter 2024 Boston, July 31, 2024 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for the second quarter ended June 30, 2024. Visit Amwell’s investor relations website at to view the second quarter 2024 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, Wednesday, July 31. The call can be accessed via a live audio webcast at or by dialing 1-888-510-2008 for U.S. particip...
Amwell® to Report Second Quarter 2024 Operating Results Boston, July 17, 2024 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in hybrid care enablement, will report its second quarter 2024 operating results on Wednesday, July 31. Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The audio webcast can be accessed by visiting the of the company's website. Alternatively, participants can call (888) 510-2008...
Amwell Announces Reverse Stock Split Boston, June 28, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a small-cap growth healthcare company and a leading provider of healthcare software as a service, today announced that its Board of Directors (the “Board”) has approved a 1-for-20 reverse stock split (“Reverse Split”) of its Class A common stock, Class B common stock and Class C common stock (collectively, the “Common Stock”), that is expected to become effective on July 10, 2024 at 5:00 p.m. EDT. The shares of the Company’s Class A common stock are expected to begin trading on the New Yor...
Amwell Announces Appointment of Ricky Goldwasser to its Board of Directors Boston, June 17, 2024 (GLOBE NEWSWIRE) -- (NYSE: AMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's , effective June 13. “Ricky brings to our board a deep financial background that makes her an invaluable addition as we focus on Amwell’s path to profitability. Ricky’s strong voice coupled with her impressive track record will help guide Amwell as we strive for greater efficiencies, optimized cash flow and profitable growth, while remaining committed to...
Amwell Co-Founder Roy Schoenberg Becomes Executive Vice Chairman of the Board Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility Boston, June 13, 2024 (GLOBE NEWSWIRE) -- (NYSE: AMWL), a leader in digital care, today announced that co-founder and visionary healthcare technology leader Roy Schoenberg, M.D., M.P.H., is transitioning from his role as president and co-CEO to become Executive Vice Chairman of Amwell’s Board of Directors. Ido Schoenberg, M.D., will assume the role of sole Chief Exe...
Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility Boston, May 16, 2024 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in hybrid care enablement, today announced its Co-CEO and President, Roy Schoenberg, M.D., M.P.H., will speak at the at 12:15 PST on Saturday, May 18. The virtual conference explores barriers to telehealth enhancement for those with disabilities and the innovative solutions underway to advance hea...
AMWELL ANNOUNCES RESULTS FOR FIRST QUARTER 2024 Boston, May 01, 2024 (GLOBE NEWSWIRE) -- (NYSE: AMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for the first quarter ended March 31, 2024. Visit Amwell’s investor relations website at to view the first quarter 2024 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, Wednesday, May 1. The call can be accessed via a live audio webcast at or by dialing 1-888-510-2008 for U.S. participants or...
Amwell Releases 2024 Corporate Responsibility Report Report demonstrates company progress toward enabling digital healthcare with purpose Boston, April 29, 2024 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in hybrid care enablement, today announced the release of its 2024 Corporate Responsibility Report, which details the company’s latest progress across environmental, social, and governance (ESG) topics and highlights Amwell’s growing positive impact on key stakeholders and the communities it serves. “Corporate responsibility is fundamental to our mission to transform healthcare, wh...
Amwell to Participate in Upcoming Investor Conference Boston, April 25, 2024 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in hybrid care enablement, announced that the company will participate in the Needham Technology, Media and Consumer Conference. Robert Shepardson, Amwell chief financial officer, will participate in a fireside chat on Tuesday, May 14, at a time to be determined, along with one-on-one investor meetings throughout the day. An audio webcast of the fireside chat will be available at About Amwell Amwell is a leading hybrid care delivery enablement platform ...
Amwell® to Report First Quarter 2024 Operating Results May 1 Boston, April 17, 2024 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in hybrid care enablement, will report its first quarter 2024 operating results Wednesday, May 1. Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The audio webcast can be accessed by visiting the of the company's website. Alternatively, participants can call (888) 510-2008...
Amwell Receives Continued Listing Standard Notice From NYSE Amwell’s Class A Common Stock continues to trade on the NYSE Boston, April 04, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of healthcare software as a service, today announced that it received a notice on April 2, 2024 from the New York Stock Exchange (NYSE) informing the company that it is not in compliance with the NYSE’s continued listing minimum price criteria with respect to its Class A common stock because the average closing price of the company’s Class A common stock was less than $1 per share over...
Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024 Amwell clients to present on automated care, Converge platform integration Boston, March 06, 2024 (GLOBE NEWSWIRE) -- (NYSE: AMWL), a leader in hybrid care enablement, is attending , March 11-15, in Orlando, Fla. Company leaders will be in booth #1441 to discuss Amwell’s hybrid care enablement platform, Virtual Nursing solution, automated care and behavioral health programs and how this technology can address workforce shortages, access to care, the mental health crisis and other industry challenges. In addition,...
Amwell Names Cynthia Horner, M.D., Chief Medical Officer Horner brings to the role 25 years in family medicine, completion of 25,000 virtual care visits Boston, Feb. 22, 2024 (GLOBE NEWSWIRE) -- (NYSE: AMWL), a leader in hybrid care enablement, named Cynthia Horner, M.D., FAAFP, as its chief medical officer. Horner has also been named president of Amwell’s clinical partner, Amwell Medical Group (AMG), a nationwide network of clinicians delivering virtual care 24 hours a day, every day, exclusively on the Amwell platform. As chief medical officer, Horner will partner with hospital s...
Amwell Expands Presence in Australia with Amplar Health Partnership Amplar Health to leverage Amwell’s digital care technology for chronic disease prevention programs Boston & Melbourne, Australia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in hybrid care enablement, announced today that it has partnered with to expand access to hybrid and digital care programs across Australia. Amplar Health partnered with Amwell to support delivery of its prevention programs to reach more Australians at risk of chronic disease. The Amwell Automated Care platform will provide Ampla...
Amwell to Participate in Upcoming Investor Conference Boston, Feb. 21, 2024 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in hybrid care enablement, announced that company executives will participate in the TD Cowen Health Care Conference on Tuesday, March 5 in Boston. Ido Schoenberg, M.D., Amwell chairman and co-CEO, and Robert Shepardson, Amwell CFO, will participate in a fireside chat at 10:30 a.m. ET, along with one-on-one meetings throughout the day. An audio webcast of the fireside chat will be available at . About Amwell Amwell is a leading hybrid care, delivery enabl...
Amwell Executives to Take the Stage at ViVE 2024 Company leaders to moderate or speak at sessions on virtual care delivery, GLP-1s Boston, Feb. 15, 2024 (GLOBE NEWSWIRE) -- (NYSE: AMWL), a leader in hybrid care enablement, will attend , Feb. 25-28, in Los Angeles. Executives will be onsite to discuss the company’s hybrid care enablement platform, virtual nursing, automated care, and digital behavioral health programs and how technology can address workforce shortages, access to care, the mental health crisis and other industry issues. In addition, two Amwell executives will lead or ...
Amwell Announces Results for Fourth Quarter and Full Year 2023 Boston, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL) a leader in hybrid care enablement, today announced financial results for the fourth quarter and full year ended Dec. 31, 2023. Amwell is a small-cap growth company and a leading provider of healthcare software as a service. Visit Amwell’s investor relations website at to view the fourth quarter and full year 2023 earnings report. Amwell will host a conference call to discuss its financial results today at 5 p.m. ET, Wednesday, Feb.14. The call can be acces...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.